A Study of Cannabis Oil for Pain Effectiveness (COPE)

Trial ID: NCT03522467
Kidney Cancer Type: Any


Cannabis is a psychoactive drug produced by the Cannabis plant. The effects of the drug are caused by a group of compounds known as cannabinoids, of which THC and CBD are the most widely known.

Due to its long-standing designation as a controlled substance, there are very few scientific studies regarding the potential medical applications of cannabis. Despite this, there is preliminary evidence that cannabis may be used to help alleviate cancer-associated pain.

This study represents the first clinical trial of cannabis for the treatment of poorly controlled pain among cancer patients.

The Trial:

Patients enrolling on this trial will receive a whole-plant cannabis oil extract, taken as a capsule once per day. This will be administered as an add-on therapy to your current treatment regimen.

Patients will receive increasing doses until a sustained pain response is reached, after which they will be monitored for safety and the durability of their pain response for 12 weeks.

Basic Eligibility:

  • Age 25-70 years
  • Cancer has not spread to the brain
  • No prior use of cannabis within 30 days of trial enrollment

Additional eligibility criteria may apply. Please speak to your doctor.

Find out more about this study.
Hospital / Cancer CentrePrincipal InvestigatorLocationTrial Status
Hospital / Cancer CentreJuravinski Cancer Centre Principal InvestigatorDr. Marissa Slaven LocationHamilton, Ontario Trial StatusRecruiting
Do NOT follow this link or you will be banned from the site!